Invivyd, Inc. (IVVD) awards 820,000 stock options to Chief Legal Officer

Rhea-AI Filing Summary

Invivyd, Inc. reported that its Chief Legal Officer and Secretary, Jill Andersen, received a new stock option award. On January 29, 2026, she was granted an option to buy 820,000 shares of Invivyd common stock at an exercise price of $1.85 per share.

The option vests over three years, with 1/36th of the shares vesting in substantially equal monthly installments starting one month after the grant date, conditioned on her continued service. After this grant, she beneficially owns 820,000 stock options directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andersen Jill

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer, Secretary

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.85	01/29/2026		A		820,000		(1)	01/28/2036	Common Stock	820,000	$0.00	820,000	D

Explanation of Responses:

1. This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date.

	/s/ Jill Andersen	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Invivyd (IVVD) report for Jill Andersen?

Invivyd reported that Chief Legal Officer Jill Andersen received a stock option grant for 820,000 shares. The options allow her to buy Invivyd common stock at an exercise price of $1.85 per share, subject to a three-year vesting schedule tied to continued service.

How many Invivyd (IVVD) stock options were granted to Jill Andersen?

Jill Andersen was granted stock options covering 820,000 shares of Invivyd common stock. These options vest in 36 substantially equal monthly installments over three years, beginning one month after the January 29, 2026 grant date, contingent on her continued employment with the company.

What is the exercise price of Jill Andersen’s Invivyd (IVVD) stock options?

The exercise price of Jill Andersen’s Invivyd stock options is $1.85 per share. This means she may purchase Invivyd common stock at $1.85 per share upon vesting and exercise, according to the option’s terms and the three-year monthly vesting schedule.

What is the vesting schedule for Jill Andersen’s Invivyd (IVVD) option grant?

The option vests over three years, with 1/36th of the shares vesting monthly. Vesting begins one month after the January 29, 2026 grant date and requires Jill Andersen’s continuous service with Invivyd as of each vesting date for the corresponding portion to vest.

How many Invivyd (IVVD) derivative securities does Jill Andersen own after this transaction?

Following the reported transaction, Jill Andersen beneficially owns 820,000 derivative securities in the form of stock options. All of these options are held directly and relate to Invivyd common stock, subject to the stated exercise price and vesting conditions in the grant.